|
Eli Lilly and Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1033
|
$957B |
15.0x |
33.2x |
|
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$219
|
$554B |
5.9x |
15.5x |
|
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$217
|
$446B |
7.3x |
17.1x |
|
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 347
|
$372B |
4.8x |
12.1x |
|
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£143
|
$324B |
5.5x |
15.9x |
|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$111
|
$299B |
4.6x |
10.0x |
|
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 114
|
$298B |
5.4x |
13.2x |
|
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 378
|
$273B |
5.7x |
11.7x |
|
Thermo Fisher Scientific
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Supplies
|
$622
|
$266B |
6.0x |
23.8x |
|
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$330
|
$223B |
6.1x |
12.6x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$26
|
$191B |
3.1x |
7.7x |
|
Danaher
|
United States of America |
Medical Devices,
Laboratory Services,
Medical Supplies
|
$240
|
$185B |
7.5x |
24.2x |
|
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$121
|
$168B |
5.8x |
10.5x |
|
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$57
|
$150B |
3.1x |
8.0x |
|
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€83
|
$125B |
2.4x |
7.9x |
|
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£19
|
$122B |
2.8x |
8.2x |
|
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$439
|
$107B |
8.9x |
19.8x |
|
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€42
|
$85.9B |
1.6x |
7.7x |
|
Chugai Pharmaceutical Co
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 8594
|
$84.6B |
10.7x |
20.9x |
|
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 5176
|
$77.1B |
2.7x |
9.9x |
|
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€127
|
$75.2B |
3.0x |
10.6x |
|
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$754
|
$73.5B |
5.2x |
14.7x |
|
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 175
|
$66.6B |
4.1x |
12.2x |
|
Samsung BioLogics
|
South Korea |
Contract Research & Manufacturing
|
KRW 1965000
|
$62.3B |
15.6x |
33.6x |
|
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$126
|
$60.6B |
6.4x |
14.7x |
|
IDEXX Laboratories
|
United States of America |
Medical Devices,
Laboratory Services,
Healthcare Software
|
$710
|
$57.6B |
13.4x |
38.6x |
|
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€254
|
$57.4B |
6.7x |
21.6x |
|
Jiangsu Hengrui Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 63
|
$54.4B |
11.5x |
38.2x |
|
Haleon
|
United Kingdom of Great Britain and Northern Ireland |
Health & Beauty,
Drug Development & Therapeutics
|
£4
|
$54.3B |
3.6x |
14.5x |
|
IQVIA
|
United States of America |
Contract Research & Manufacturing,
Health Data & Analytics,
Healthcare Software
|
$241
|
$54.3B |
3.4x |
14.4x |
|
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 564
|
$54.2B |
5.7x |
19.5x |
|
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 102
|
$51.5B |
3.0x |
10.1x |
|
Galderma Group
|
Switzerland |
Health & Beauty,
Drug Development & Therapeutics
|
CHF 158
|
$48.8B |
9.5x |
41.1x |
|
Fresenius
|
Germany |
Hospitals & Clinics,
Medical Supplies,
Drug Development & Therapeutics
|
€52
|
$47.1B |
1.8x |
10.6x |
|
argenx
|
Belgium |
Drug Development & Therapeutics
|
€697
|
$46.5B |
11.1x |
39.0x |
|
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$359
|
$46.0B |
12.3x |
65.7x |
|
Agilent
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Imaging & Diagnostics
|
$146
|
$42.9B |
6.2x |
21.2x |
|
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1701
|
$42.7B |
6.8x |
24.0x |
|
Wuxi AppTec
|
China |
Contract Research & Manufacturing,
Laboratory Services
|
CNY 104
|
$40.8B |
6.4x |
14.2x |
|
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3401
|
$37.7B |
2.9x |
14.2x |
|
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 61
|
$37.2B |
3.4x |
15.7x |
|
BeOne Medicines
|
Hong Kong |
Drug Development & Therapeutics
|
HKD 217
|
$37.0B |
7.0x |
70.3x |
|
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 210500
|
$33.1B |
11.6x |
32.4x |
|
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$159
|
$32.9B |
63.9x |
-29.3x |
|
Mettler Toledo
|
United States of America |
Laboratory Services,
Medical Devices
|
$1497
|
$32.7B |
8.2x |
26.2x |
|
Natera
|
United States of America |
Genomics & Personalized Medicine,
Medical Imaging & Diagnostics
|
$240
|
$32.7B |
14.7x |
-98.6x |
|
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2302
|
$29.1B |
2.3x |
9.6x |
|
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 9206
|
$29.1B |
1.9x |
7.8x |
|
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 43
|
$29.1B |
13.8x |
35.8x |
|
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$13
|
$28.7B |
2.0x |
7.0x |
|
Labcorp
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$262
|
$27.7B |
2.0x |
11.5x |
|
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$169
|
$27.4B |
2.8x |
9.0x |
|
Quest Diagnostics
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$187
|
$26.7B |
2.4x |
12.2x |
|
Sartorius Stedim Biotech
|
France |
Medical Devices,
Laboratory Services,
Contract Research & Manufacturing
|
€210
|
$26.4B |
7.6x |
24.9x |
|
Waters
|
United States of America |
Laboratory Services,
Medical Devices
|
$395
|
$24.5B |
7.8x |
21.7x |
|
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$40
|
$24.3B |
8.2x |
8.4x |
|
Illumina
|
United States of America |
Genomics & Personalized Medicine,
Laboratory Services
|
$145
|
$23.5B |
5.5x |
19.7x |
|
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 10
|
$22.5B |
2.2x |
6.3x |
|
Revolution Medicines
|
United States of America |
Drug Development & Therapeutics
|
$123
|
$22.1B |
5737.5x |
-19.5x |
|
Exact Sciences
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$102
|
$21.0B |
6.5x |
44.0x |
|
Insulet
|
United States of America |
Medical Devices,
Drug Delivery Systems
|
$286
|
$20.4B |
7.6x |
31.6x |
|
Wuxi Biologics
|
Hong Kong |
Contract Research & Manufacturing
|
HKD 40
|
$20.2B |
6.5x |
18.8x |
|
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 89
|
$18.8B |
9.7x |
95.3x |
|
Eurofins Scientific
|
France |
Laboratory Services,
Contract Research & Manufacturing
|
€72
|
$18.7B |
2.2x |
10.0x |
|
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 318
|
$18.4B |
58.3x |
N/A |
|
Divi's Laboratories
|
India |
Contract Research & Manufacturing,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 6356
|
$18.4B |
16.0x |
49.1x |
|
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 2251
|
$18.4B |
5.0x |
13.2x |
|
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$105
|
$17.8B |
3.6x |
11.2x |
|
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€10
|
$17.5B |
2.0x |
8.2x |
|
Medpace
|
United States of America |
Contract Research & Manufacturing,
Medical Devices
|
$618
|
$17.2B |
6.9x |
31.2x |
|
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$472
|
$17.2B |
5.4x |
10.3x |
|
ICON plc
|
United States of America |
Contract Research & Manufacturing,
Healthcare Software,
Health Data & Analytics
|
$185
|
$17.2B |
2.1x |
10.9x |
|
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 470500
|
$17.1B |
110.4x |
205.5x |
|
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$78
|
$16.2B |
32.9x |
-35.4x |
|
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$24
|
$15.5B |
3.3x |
17.5x |
|
Revvity
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics,
Health Data & Analytics
|
$115
|
$15.5B |
5.5x |
18.3x |
|
Torrent Pharmaceuticals
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 4004
|
$15.3B |
10.9x |
33.0x |
|
Biomerieux
|
France |
Laboratory Services,
Medical Imaging & Diagnostics
|
€108
|
$15.0B |
3.1x |
12.6x |
|
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 7
|
$15.0B |
3.1x |
11.6x |
|
Regencell Bioscience
|
United States of America |
Drug Development & Therapeutics
|
$30
|
$14.9B |
N/A |
N/A |
|
Guardant Health
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$109
|
$14.9B |
15.3x |
-70.1x |
|
Zhangzhou Pientzehuang
|
China |
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
CNY 169
|
$14.6B |
10.2x |
32.2x |
|
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 341
|
$14.2B |
4.6x |
11.9x |
|
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 122
|
$14.1B |
29.7x |
-1397.4x |
|
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€48
|
$13.9B |
4.5x |
12.2x |
|
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$171
|
$13.8B |
3.3x |
14.7x |
|
Ascendis Pharma
|
Germany |
Drug Development & Therapeutics
|
€187
|
$13.6B |
N/A |
N/A |
|
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 470
|
$13.5B |
48.0x |
-290.8x |
|
Charles River
|
United States of America |
Contract Research & Manufacturing,
Laboratory Services
|
$223
|
$13.4B |
3.4x |
14.2x |
|
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 26
|
$13.2B |
2.3x |
14.0x |
|
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 10
|
$13.1B |
3.3x |
13.1x |
|
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$17
|
$12.6B |
N/A |
-12.3x |
|
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$133
|
$12.6B |
4.4x |
19.1x |
|
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 56
|
$12.6B |
2.1x |
14.2x |
|
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€136
|
$12.4B |
2.8x |
7.4x |
|
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2938
|
$12.4B |
4.0x |
10.0x |
|
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$41
|
$12.1B |
6.3x |
-3.8x |
|
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$79
|
$12.0B |
13.4x |
-32.6x |
|
Roivant Sciences
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$23
|
$11.9B |
649.4x |
-10.6x |
|
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1435
|
$11.8B |
3.7x |
15.2x |